Social Media Ideas for Emerging Therapy

<![CDATA[Steer Bio Targets Lymphedema with Regenerative Cell Therapy Platform]]>

Four Ways Health Systems Should Plan for the Next Wave of Breakthrough Therapies

Groundbreaking new therapies have exciting potential to treat and cure diseases while minimizing burden on patients; however, they create major clinical, operational and financial...

Proposing the Synergy of Therapeutic Plasma Exchange and Partial Epigenetic Reprogramming

It seems a little early in the development of partial epigenetic reprogramming as a class of therapy to be thinking about which of the other approaches to aging it can best be comb...

The New Wave Of Therapy Gen Z Is Talking About

Accelerated resolution therapy is a method that is getting a lot of attention. It helps people process painful memories. The post The New Wave Of Therapy Gen Z Is Talking About app...

Gene and Disease-Modifying Therapies for Hemophilia

Inside the evolving hemophilia treatment landscape, including AAV-based gene therapies, non-factor prophylaxis, and approaches that aim to reduce treatment burden. The post Gene an...

<![CDATA[How New Therapies are Tackling Unmet Needs in IBS]]>

Advanced Therapies Bring New Hope to Blood Cancer Patients in India

Mumbai (Maharashtra) [India], September 2: A blood cancer diagnosis is abrupt and overwhelming. When families hear terms like Acute Myeloid Leukemia or Hodgkin Lymphoma, finding ge...

<![CDATA[What if patient onboarding evolved alongside today's therapies?]]>

Novel Epigenetic Therapy Targets Treatment-Resistant and TP53-Mutant AML

The results of a preclinical study across multiple models of acute myeloid leukemia found that the investigational hypomethylating agent, NTX-301 remained effective in treatment-re...

Developing a Global Clinical Trial Strategy for Emerging Biotechs

Discussing how small biotechs can accelerate clinical development with fit-for-purpose global clinical trial strategies.

Regenerative Medicine Innovations Shaping The Future Of Healthcare

Healthcare looks different today than it did a decade ago. Patients now expect treatments that support recovery, reduce long-term complications, and improve quality of life. Resear...

Regulatory T cell reprogramming heads to trial in 2026

Most people have heard of cancer immunotherapy by now. These treatments help a patient’s own immune system recognize and attack cancer. The best-known examples are immune checkpoin...

World-first virus therapy for esophageal cancer debuts in Japan

First-in-Class Takeda, Protagonist Drug Lands FDA Approval in Rare Blood Disorder

Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic options. Originally developed by Protagonist Therapeuti...

As Food Allergy Treatments Become Big Business, Pharma Bets on VT-7208

Pharma is betting big on an experimental oral drug targeting BTK that is advancing toward Phase 2 trials for food allergy, chronic hives, and multiple sclerosis. The post As Food A...

Cellogen Therapeutics is developing CAR-T cell therapies for blood cancers in India

The Delhi company designs and manufactures its own cell and gene therapies and is preparing a first clinical trial with Christian Medical College, Vellore.

How New Science is Reshaping Ovarian Cancer Treatment and Care

Ovarian cancer is often diagnosed at an advanced stage, but research is reshaping how scientists understand and treat the disease. From discoveries about its origins to new FDA-app...

Hematogenix's Proprietary MM MRD Assay Underpins FDA Accelerated Approval of Bristol Myers Squibb's ZENBEXUSâ„¢, the Fir...

Hematogenix's proprietary Multiple Myeloma MRD (MM MRD) assay measured the primary efficacy endpoint cited in the FDA-approval of ZENBEXUS (iberdomide), reinforcing Hematogenix's r...

Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy

One analyst views Roivant’s pulmonary hypertension drug as a future $10 billion-plus seller. Elsewhere, AstraZeneca overcame a negative advisory committee vote and Pharvaris claime...

Embedding Regulatory Strategy in Cell and Gene Therapy Development

In this GEN webinar, experts from Rose BioSolutions, a CDMO and Cell Solutions organization formed from Charles River Laboratories’ businesses, will discuss how integrating regulat...

Extracorporeal Magnetotransduction Therapy (EMTT)

Extracorporeal Magnetotransduction Therapy (EMTT) for Midfoot Osteoarthritis: A Prospective Pilot Study of Pain and Functional Outcomes Rohan Charles et al J Am Podiatr Med Assoc....

From the Bench, AACR D3 2026: Emerging Therapeutic Strategies to Inhibit KRAS, Enhance ADCs, and Tackle Resistance

The AACR D3 edition of “From the Bench” highlights cutting-edge approaches from the meeting that could shape the next generation of cancer treatments. We spoke with Andrea Wang-Gil...

In vivo CAR T Industry Leaps Forward with Challenges Ahead

The emerging new class of in vivo CAR T therapeutics is seen by regulators as gene therapies with risks of off-target effects to patients. Manufacturers need to rise to the challen...

FDA backs faster development path for Parkinson’s cell therapy

The U.S. Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to sasineprocel (ANPD001), an experimental cell therapy to treat P...